Axa
CBPO

Axa’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Axa’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-128,220
Closed -$11.8M – 1428
2017
Q3 		$11.8M Buy
128,220
+33,886
+36% +$3.26M 0.05% 390
2017
Q2 		$10.7M Buy
94,334
+14,068
+18% +$1.57M 0.05% 410
2017
Q1 		$8.04M Buy
80,266
+3,472
+5% +$371K 0.04% 468
2016
Q4 		$8.26M Buy
76,794
+16,706
+28% +$1.95M 0.04% 457
2016
Q3 		$7.48M Buy
+60,088
New +$7.09M 0.03% 488

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Axa's CBPO Position: Q4 2017 in Review

Axa sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 128,220 shares — an estimated $11.8M sold.

Axa first reported a position in CBPO in Q3 2016 and held it in 5 quarters. The position peaked at $11.8M in Q3 2017. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • Axa reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Axa sold 128,220 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $11.8M.
  • Axa first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 5 quarters.
  • Axa's China Biologic Products Holdings, Inc. position peaked at $11.8M in Q3 2017.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.